InvestorsHub Logo
Followers 1326
Posts 248914
Boards Moderated 64
Alias Born 12/07/2009

Re: None

Tuesday, 07/11/2023 12:21:08 PM

Tuesday, July 11, 2023 12:21:08 PM

Post# of 2792
$NBIO Nascent Biotech Inc. is an emerging player in the $4 billion oncology drug development space with a legitimate IP asset possibly heading into Phase 2 clinical research for its first flagship pipeline asset. https://www.benzinga.com/pressreleases/23/07/33177689/why-nbio-is-a-biotech-bargain-basement-deal-with-underappreciated-potential
Bullish
Bullish

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News